Rheumatoid arthritis (RA) is a chronic autoimmune disease of the connective tissue of synovial joints, which is characterized by nonspecific symmetrical inflammation of the surrounding joints, which can lead to progressive destruction of joints and surrounding structures, eventually leading to Sports injuries and disabilities. Rheumatoid arthritis medications are medications developed for different therapeutic targets of this type of disease.
This report contains market size and forecasts of Rheumatoid Arthritis (RA) Medications in global, including the following market information:
Global Rheumatoid Arthritis (RA) Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rheumatoid Arthritis (RA) Medications Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rheumatoid Arthritis (RA) Medications companies in 2021 (%)
The global Rheumatoid Arthritis (RA) Medications market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
TNFα Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis (RA) Medications include AbbVie, Pfizer, Boehringer Ingelheim, Bayer, Novartis, Regeneron Pharmaceuticals, Bristol-Myers Squibb, Roche and UCB S.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatoid Arthritis (RA) Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis (RA) Medications Market, by Target, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rheumatoid Arthritis (RA) Medications Market Segment Percentages, by Target, 2021 (%)
TNFα
CTLA4
CD20
IL-6
Global Rheumatoid Arthritis (RA) Medications Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rheumatoid Arthritis (RA) Medications Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Rheumatoid Arthritis (RA) Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rheumatoid Arthritis (RA) Medications Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis (RA) Medications revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rheumatoid Arthritis (RA) Medications revenues share in global market, 2021 (%)
Key companies Rheumatoid Arthritis (RA) Medications sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rheumatoid Arthritis (RA) Medications sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Pfizer
Boehringer Ingelheim
Bayer
Novartis
Regeneron Pharmaceuticals
Bristol-Myers Squibb
Roche
UCB S.A.
Johnson & Johnson
Amgen
Merck
Mitsubishi Tanabe Pharma
Biogen
Sanofi
Alder
Ablynx
AstraZeneca
Incyte
Galapagos
Hanwha Biologics
CPGJ
Celgen Pharm
Hisun